 |
| PSID makes Major Mid Year Update. New Audio with PZOO ISCO MJNA |
|
 Yesterday's Top Performer |
Company: Allezoe Medical Holdings Inc. (OTCQB: ALZM) |
End of Day:
Price: 0.005
Change (%): + 0.0005 (11.11)
Volume: 3,968,775 |
 |
Allezoe Medical Holdings (ALZM) Announces Subsidiary to Receive European Union Patent
BOCA RATON, FLORIDA - (Marketwire) - 08/22/12 - Allezoe Medical Holdings, Inc. (OTCBB:ALZM) announced today that its SureScreen Medical, Inc. subsidiary has received notice from the European Patent Office that it intends to grant the requested patent for the "see and treat" HPV virus diagnosis and treatment technology SureScreen is developing under an exclusive license, as soon as the remaining procedural steps have been completed. As a result, SureScreen has filed German and French claims translations at the European Patent Office together with the necessary request for further processing of the patent application for the technology. With completion of these actions, all of the procedural steps for the grant of the patent now have been undertaken, and the application has been placed in the queue for publication as a granted patent. The US patent application remains under review by the US Patent & Trademark Office.
Continue Reading |
 Hot Stock to Watch |
Company: PositiveID Corporation (OTCBB: PSID) |
End of Day:
Price: 0.0118
Change (%): - 0.0007 (5.60)
Volume: 2,026,559 |
 |
PositiveID Corporation Provides Mid-Year Update to Stockholders
DELRAY BEACH, Fla., Aug. 23, 2012 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), an emerging growth company and developer of sophisticated airborne bio-threat detection systems for America's homeland security, today announced a mid-year update and the significant progress it has made realigning its business with a focus on its molecular diagnostics platform. The Company also continues to make strong progress in the diabetes management segment of its business.
Continue Reading |
SmallCapVoice Clients' News
|
Company: Omega Commercial Finance Corp. (OTCQB: OCFN) |
Omega Becomes a Member of OTC Markets
MIAMI BEACH, FL - (Marketwire) - 08/22/12 - Omega Commercial Finance Corporation (OTCQB: OCFN) has become a member of OTC Market Inc., which offers market data, transparency, and disclosure services to the capital markets. OTC Market Inc. offers products and services that track performance, promotes transparency, and facilitates price discovery and compliance regulations. These services are simple yet convenient tools that can help maximize market information and accessibility for OCFN's shareholders. OCFN is currently quoted as an "OTCQB" fully reporting company achieved on August 8th, 2012. The President and Chairman Jon S. Cummings IV states, "I feel this was a giant first step and integral part of our growth strategy in which I intend to build upon moving forward."
Continue Reading
|
Company: Pazoo Inc. (OTCQB: PZOO) |
A New Audio Interview With David Cunic, CEO, of Pazoo.com, is Now at SmallCapVoice.com
AUSTIN, Texas, Aug. 23, 2012 (GLOBE NEWSWIRE) - SmallCapVoice.com, Inc. announced today that a new audio interview with the #1 online health and wellness social community for people and their pets, is now available. The interview can be heard at http://smallcapvoice.com/blog/8-17-12-smallcapvoice-interview-with-pazoo-inc-otcqb-pzoo
Continue Reading
PAZOO Prepares For First Three National Direct Response Campaigns and Distribution of PAZOO Branded Products
CEDAR KNOLLS, N.J., Aug. 23, 2012 /PRNewswire/ - Pazoo, Inc. (OTCBB: PZOO) announces the national roll-out of the first direct response products being marketed under the PAZOO brand name. The initial launch, expected in September 2012, targets adults with a nutritional supplement, stem-cell nutritional product and an anti-aging product. The new PAZOO branded items will be sold at www.pazoo.com, through a digital direct response campaign and is expected to be introduced to brick and mortar retailers soon.
Continue Reading
|
Company: Medical Marijuana Inc. (Pink Sheets: MJNA) |
Medical Marijuana Inc. Product, CanChew Bio-Technologies
Founder Interviews With Small Cap Voice Internet Radio Program
SAN DIEGO, Aug. 23, 2012 /PRNewswire/ - Medical Marijuana Inc. (OTC: MJNA), a leading hemp industry innovator, is pleased to welcome Dr. Philip Van Damme, Director for CanChew Biotechnologies, to Small Cap Voice's Internet radio network. Dr. Van Damme, a Netherlands-trained surgeon, is eager to share why and how he invented the revolutionary Non-THC CanChew gum. Its tremendous medical potential will offer a new treatment for pain-afflicted people in the U.S. and beyond.
Continue Reading |
Other Small Cap News
|
Company: Stem Cell Corporation (OTCBB: ISCO) |
SmallCapVoice Announces a New Audio Interview With Dr. Simon Craw, Executive Vice President of International Stem Cell Corporation
AUSTIN, Texas, Aug. 23, 2012 (GLOBE NEWSWIRE) -- SmallCapVoice announced today that a new audio interview with International Stem Cell Corporation (ISCO) (www.internationalstemcell.com), a California-based biotechnology company focused on therapeutic and research products, is now available. The interview can be heard at http://smallcapvoice.com/blog/8-16-12-smallcapvoice-interview-with-international-stem-cell-corporation-otcbb-isco
The interview includes an overview of the markets being targeted by ISCO and its subsidiary companies, the goals for the companies in 2012, and the major achievements of the companies to date.
Continue Reading |
Company: Strikeforce Technologies, Inc. (OTCBB: SFOR) |
StrikeForce Technologies, Inc., Information to Be Available Through S&P Capital Market Access Program
EDISON, NJ--(Marketwire - Aug 23, 2012) - StrikeForce Technologies, Inc. (OTCBB: SFOR), creators of "Out-of-Band" authentication and anti-keylogging keystroke encryption, today announced that company information will be made available via S&P Capital IQ's Market Access Program, an information distribution service that enables subscribing publicly traded companies to have their company information disseminated to users of S&P Capital IQ's MarketScope Advisor.
Continue Reading |
Company: Stellar Pharmaceuticals Inc. (OTCQB: SLXCF) |
Stellar Pharmaceuticals Enters Into a Partnership With Pfizer Canada Inc. to Promote Gelfoam® in Canada
Gelfoam® is a medical device approved in Canada and the United States for use in surgical procedures as a haemostatic agent, when control of capillary, venous, and arteriolar bleeding by pressure, ligature, and other conventional procedures is either ineffective or impractical. "Gelfoam® is an absorbable haemostatic device used in hospitals and surgical centres across Canada" noted Mr. Rob Harris, President & CEO of Stellar. "The addition of Gelfoam is another step forward as we expand our hospital, specialty care business, which is a target area of growth for Stellar."
Continue Reading |
Market News
|
By Jason Lange: Reuters |
Weakness in labor, factory data send sour signals
The number of Americans filing new claims for jobless benefits unexpectedly rose last week while U.S. manufacturing improved only slightly in August, worrisome signs for an economy struggling to create enough jobs.
Initial claims for state unemployment benefits rose 4,000 to a seasonally adjusted 372,000, the Labor Department said on Thursday.
The data keeps pressure on President Barack Obama ahead of his November re-election bid. Republican challenger Mitt Romney is trying to focus voters' attention on a lofty unemployment rate that has dogged Obama's presidency.
Continue Reading |
By Jeff Macke: Breakout |
Are Low Volumes Really Bearish?
According to WSJ market data, average turnover this month has been just 4.8 billion shares daily. The volume is a far cry from 8 billion and nearly 6 billion shares a day in August 2011 and 2010 respectively. Another WSJ article this morning suggests the low volumes are causing investors to question the sustainability of the rally that's taken stocks over 8% higher since early June.
Lee Munson, author of Rigged Money and founder of Portfolio LLC takes the other side of the argument. Volume matters, but the way it's measured hasn't changed to reflect modern markets. "There's a reason for us as investors to change the way we look at and analyze volume," he says.
Continue Reading |
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
